Apollo Hospitals Enterprise Share Price
Sector: Healthcare Facilities
7100.00 +60.40 (0.86%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
7019.15
Today’s High
7121.00
52 Week Low
6002.15
52 Week High
7545.10
7101.50 +59.50 (0.84%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
7020.50
Today’s High
7122.50
52 Week Low
6001.00
52 Week High
7545.35
Key Metrics
- Market Cap (In Cr) 101987.14
- Beta 0.8
- Div. Yield (%) 0.27
- P/B 12.43
- TTM P/E 65.79
- Sector P/E 22.19
- D/E 0.01
- Open Price 7043.05
- Prev Close 7039.6
Apollo Hospitals Enterprise Analysis
Price Analysis
-
1 Week1.31%
-
3 Months9.39%
-
6 Month-2.2%
-
YTD-2.67%
-
1 Year15.72%
Risk Meter
- 22% Low risk
- 22% Moderate risk
- 22% Balanced Risk
- 22% High risk
- 22% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 9
- 9
- 9
- 9
- Buy
- 13
- 13
- 12
- 12
- Hold
- 1
- 1
- 2
- 2
- Sell
- 1
- 1
- 1
- 1
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 24
- 24
- 24
- 24
Apollo Hospitals Enterprise News
Apollo HealthCo to be ₹30,000 crore company in 5-6 yrs, says Shobana Kamineni
4 min read . 26 Jun 2025These 5 Nifty stocks delivered strongest EPS gains in a weak FY25
11 min read . 16 Jun 2025Nifty 50 gains likely to mirror earnings growth; prefer large banks, IT, realty
1 min read . 10 Jun 2025Vodafone Idea, Nykaa, Apollo Hospitals and others to declare Q4 results today
2 min read . 30 May 2025Apollo Hospitals Enterprise Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 21794
- Selling/ General/ Admin Expenses Total
- 2769.2
- Depreciation/ Amortization
- 757.5
- Other Operating Expenses Total
- 4693
- Total Operating Expense
- 19529.7
- Operating Income
- 2264.3
- Net Income Before Taxes
- 2006.1
- Net Income
- 1445.9
- Diluted Normalized EPS
- 100.56
- Period
- 2025
- Total Assets
- 20657.4
- Total Liabilities
- 12445.1
- Total Equity
- 8212.3
- Tangible Book Valueper Share Common Eq
- 479.37
- Period
- 2025
- Cashfrom Operating Activities
- 2136.4
- Cashfrom Investing Activities
- -3380.6
- Cashfrom Financing Activities
- 1316.8
- Net Changein Cash
- 72.6
- Period
- 2024
- Total Revenue
- 19059.2
- Selling/ General/ Admin Expenses Total
- 6833.3
- Depreciation/ Amortization
- 686.4
- Other Operating Expenses Total
- 24.1
- Total Operating Expense
- 17348
- Operating Income
- 1711.2
- Net Income Before Taxes
- 1362.5
- Net Income
- 898.6
- Diluted Normalized EPS
- 62.58
- Period
- 2024
- Total Assets
- 16753.1
- Total Liabilities
- 9817.7
- Total Equity
- 6935.4
- Tangible Book Valueper Share Common Eq
- 402.5
- Period
- 2024
- Cashfrom Operating Activities
- 1920.3
- Cashfrom Investing Activities
- -1537.2
- Cashfrom Financing Activities
- -311.1
- Net Changein Cash
- 72
- Period
- 2023
- Total Revenue
- 16612.5
- Selling/ General/ Admin Expenses Total
- 5939.1
- Depreciation/ Amortization
- 614.8
- Other Operating Expenses Total
- 31.4
- Total Operating Expense
- 15160.2
- Operating Income
- 1452.3
- Net Income Before Taxes
- 1143.7
- Net Income
- 819.1
- Diluted Normalized EPS
- 57.78
- Period
- 2023
- Total Assets
- 14427.8
- Total Liabilities
- 8230.4
- Total Equity
- 6197.4
- Tangible Book Valueper Share Common Eq
- 355.09
- Period
- 2023
- Cashfrom Operating Activities
- 1390.5
- Cashfrom Investing Activities
- -870.6
- Cashfrom Financing Activities
- -633
- Net Changein Cash
- -113.1
- Period
- 2022
- Total Revenue
- 14662.6
- Selling/ General/ Admin Expenses Total
- 4880.7
- Depreciation/ Amortization
- 600.1
- Other Operating Expenses Total
- 17.5
- Total Operating Expense
- 12778.3
- Operating Income
- 1884.3
- Net Income Before Taxes
- 1578.1
- Net Income
- 1055.6
- Diluted Normalized EPS
- 59.34
- Period
- 2022
- Total Assets
- 13269.3
- Total Liabilities
- 7646
- Total Equity
- 5623.3
- Tangible Book Valueper Share Common Eq
- 318.22
- Period
- 2022
- Cashfrom Operating Activities
- 1796.6
- Cashfrom Investing Activities
- -847.2
- Cashfrom Financing Activities
- -791.6
- Net Changein Cash
- 157.8
- Period
- 2021
- Total Revenue
- 10560
- Selling/ General/ Admin Expenses Total
- 3652.2
- Depreciation/ Amortization
- 572.5
- Other Operating Expenses Total
- 71.7
- Total Operating Expense
- 9920.6
- Operating Income
- 639.4
- Net Income Before Taxes
- 220.7
- Net Income
- 150.4
- Diluted Normalized EPS
- 8.2
- Period
- 2021
- Total Assets
- 11416.7
- Total Liabilities
- 6814.2
- Total Equity
- 4602.5
- Tangible Book Valueper Share Common Eq
- 288.02
- Period
- 2021
- Cashfrom Operating Activities
- 1256.9
- Cashfrom Investing Activities
- -872.3
- Cashfrom Financing Activities
- -340.1
- Net Changein Cash
- 44.5
- Period
- 2020
- Total Revenue
- 11246.8
- Selling/ General/ Admin Expenses Total
- 4112.3
- Depreciation/ Amortization
- 619.1
- Other Operating Expenses Total
- 39.5
- Total Operating Expense
- 10072.1
- Operating Income
- 1174.7
- Net Income Before Taxes
- 660
- Net Income
- 454.8
- Diluted Normalized EPS
- 23.48
- Period
- 2020
- Total Assets
- 11338.4
- Total Liabilities
- 7999.3
- Total Equity
- 3339.1
- Tangible Book Valueper Share Common Eq
- 211.19
- Period
- 2020
- Cashfrom Operating Activities
- 1292.8
- Cashfrom Investing Activities
- -288.8
- Cashfrom Financing Activities
- -909.5
- Net Changein Cash
- 94.5
- Period
- 2019
- Total Revenue
- 9617.44
- Selling/ General/ Admin Expenses Total
- 3831.59
- Depreciation/ Amortization
- 394.91
- Other Operating Expenses Total
- 52.06
- Total Operating Expense
- 8940.04
- Operating Income
- 677.4
- Net Income Before Taxes
- 373.54
- Net Income
- 236.05
- Diluted Normalized EPS
- 17.02
- Period
- 2019
- Total Assets
- 9183.07
- Total Liabilities
- 5849.6
- Total Equity
- 3333.47
- Tangible Book Valueper Share Common Eq
- 212.2
- Period
- 2019
- Cashfrom Operating Activities
- 904.95
- Cashfrom Investing Activities
- -710.56
- Cashfrom Financing Activities
- -214.51
- Net Changein Cash
- -20.12
- Period
- 2025-03-31
- Total Revenue
- 5592.2
- Selling/ General/ Admin Expenses Total
- 724.6
- Depreciation/ Amortization
- 211
- Other Operating Expenses Total
- 1169.3
- Total Operating Expense
- 5033.5
- Operating Income
- 558.7
- Net Income Before Taxes
- 505
- Net Income
- 389.6
- Diluted Normalized EPS
- 27.1
- Period
- 2025-03-31
- Total Assets
- 20657.4
- Total Liabilities
- 12445.1
- Total Equity
- 8212.3
- Tangible Book Valueper Share Common Eq
- 479.37
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 2136.4
- Cashfrom Investing Activities
- -3380.6
- Cashfrom Financing Activities
- 1316.8
- Net Changein Cash
- 72.6
- Period
- 2024-12-31
- Total Revenue
- 5526.9
- Selling/ General/ Admin Expenses Total
- 686.4
- Depreciation/ Amortization
- 184.6
- Other Operating Expenses Total
- 1178.3
- Total Operating Expense
- 4950
- Operating Income
- 576.9
- Net Income Before Taxes
- 530.9
- Net Income
- 372.3
- Diluted Normalized EPS
- 25.89
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 5589.3
- Selling/ General/ Admin Expenses Total
- 700.1
- Depreciation/ Amortization
- 184.5
- Other Operating Expenses Total
- 1216
- Total Operating Expense
- 4958.3
- Operating Income
- 631
- Net Income Before Taxes
- 551.7
- Net Income
- 378.8
- Diluted Normalized EPS
- 26.34
- Period
- 2024-09-30
- Total Assets
- 19547.9
- Total Liabilities
- 12046.8
- Total Equity
- 7501.1
- Tangible Book Valueper Share Common Eq
- 441.33
- Period
- 2024-09-30
- Period
- 2024-06-30
- Total Revenue
- 5085.6
- Selling/ General/ Admin Expenses Total
- 658.1
- Depreciation/ Amortization
- 177.4
- Other Operating Expenses Total
- 1129.4
- Total Operating Expense
- 4587.9
- Operating Income
- 497.7
- Net Income Before Taxes
- 418.5
- Net Income
- 305.2
- Diluted Normalized EPS
- 21.23
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 4943.9
- Selling/ General/ Admin Expenses Total
- 644.9
- Depreciation/ Amortization
- 189.7
- Other Operating Expenses Total
- 1112.8
- Total Operating Expense
- 4493.1
- Operating Income
- 450.8
- Net Income Before Taxes
- 359.6
- Net Income
- 253.8
- Diluted Normalized EPS
- 17.66
- Period
- 2024-03-31
- Total Assets
- 16753.1
- Total Liabilities
- 9817.7
- Total Equity
- 6935.4
- Tangible Book Valueper Share Common Eq
- 402.5
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 1920.3
- Cashfrom Investing Activities
- -1537.2
- Cashfrom Financing Activities
- -311.1
- Net Changein Cash
- 72
- Period
- 2023-12-31
- Total Revenue
- 4850.6
- Selling/ General/ Admin Expenses Total
- 612.9
- Depreciation/ Amortization
- 167
- Other Operating Expenses Total
- 1090.9
- Total Operating Expense
- 4403.9
- Operating Income
- 446.7
- Net Income Before Taxes
- 361.9
- Net Income
- 245.3
- Diluted Normalized EPS
- 17.06
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Apollo Hospitals Enterprise Technical
Moving Average
SMA
- 5 Day7001.03
- 10 Day7003.31
- 20 Day6951.51
- 50 Day6972.53
- 100 Day6728.68
- 300 Day6888.28
Apollo Hospitals Enterprise Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Max Healthcare Institute
- 1266.35
- 28.15
- 2.27
- 1259.85
- 837
- 123107.81
- Apollo Hospitals Enterprise
- 7100
- 60.4
- 0.86
- 7545.1
- 6002.15
- 101987.14
- Fortis Healthcare
- 792.7
- 13.05
- 1.67
- 786.3
- 452.75
- 59972.45
- Narayana Hrudayalaya
- 2070.8
- 5.85
- 0.28
- 2098.95
- 1171.35
- 42356.98
- Global Health
- 1135
- 6.6
- 0.58
- 1323.85
- 936.05
- 30454.98
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Max Healthcare Institute
- 106.94
- 12.84
- 11.25
- 15.91
- Apollo Hospitals Enterprise
- 70.03
- 12.33
- 15
- 5.46
- Fortis Healthcare
- 69.55
- 6.6
- 6.88
- 9.18
- Narayana Hrudayalaya
- 52.51
- 11.53
- 25.11
- 11.8
- Global Health
- 58.41
- 8.94
- 14.18
- 11.38
Apollo Hospitals Enterprise Shareholding
Shareholding Pattern
*Promoter pledging: 3.95%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 30-May-25
- Audited Results, Final Dividend & A.G.M.
- 10-Feb-25
- Quarterly Results & Interim Dividend
- 06-Nov-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results
- 03-Aug-24
- ESOP
- 30-May-24
- Audited Results & Final Dividend
- 08-Feb-24
- Quarterly Results & Interim Dividend
- 09-Nov-23
- Quarterly Results
- 11-Aug-23
- Quarterly Results
- 30-May-23
- Audited Results & Final Dividend
- Meeting Date
- Announced on
- Purpose
- 29-Aug-25
- 30-May-25
- AGM
- 30-Aug-24
- 30-May-24
- AGM
- 19-Aug-24
- 15-Jul-24
- POM
- 30-Aug-23
- 03-Aug-23
- AGM
- 25-Aug-22
- 25-May-22
- AGM
- 25-Aug-22
- 18-Jul-22
- AGM
- 31-Aug-21
- 22-Jul-21
- AGM
- 16-Aug-21
- 13-Jul-21
- POM
- 04-May-21
- 06-Apr-21
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 30-May-25
- 19-Aug-25
- -
- 10
- 10-Feb-25
- 15-Feb-25
- 14-Feb-25
- 9
- 30-May-24
- 17-Aug-24
- 16-Aug-24
- 10
- 08-Feb-24
- 20-Feb-24
- 20-Feb-24
- 6
- 30-May-23
- 19-Aug-23
- 18-Aug-23
- 9
- 14-Feb-23
- 24-Feb-23
- 24-Feb-23
- 6
- 25-May-22
- -
- 18-Aug-22
- 11.75
- 23-Jun-21
- -
- 18-Aug-21
- 3


